Revolymer – signs global licence with Solvay

Revolymer signs global licence to its encapsulation technology with Solvay in the field of PAP products

Revolymer, the British polymer technology company, is delighted to announce that it has signed the first licence in its prioritised Consumer Specialties business area with the international chemicals group Solvay. Under the terms of the deal, Solvay has exclusive rights to apply Revolymer’s encapsulation technology to its proprietary cleaning and disinfecting active ingredient 6-phthalimido-peroxyhexanoic acid, known as PAP and commercialised currently by Solvay under the trade mark Eureco(TM). It is intended that the resultant formulations of PAP will be more stable than existing PAP formats marketed by Solvay, thereby expanding the market for this active into a broad range of fields including cleaning, disinfection and deodorisation in both solid, gel and liquid product formats. The geographic territory of the licence is global, and Solvay intends to target industry segments including laundry detergents and additives and dish wash agents, in the consumer, domestic, industrial and institutional markets. Veterinary, pharmaceutical and other health care applications are also included in the deal. As consideration for the licence, Solvay will make royalty payments to Revolymer on net sales of PAP products incorporating Revolymer technology.

“We are excited to have closed this significant global deal applying our proprietary technology to Solvay’s PAP active ingredient. Solvay’s strategy of improving product performance for its customers is closely aligned to Revolymer’s own business plan, and, with Solvay’s global reach, it is the ideal partner for Revolymer to commercialise its technology in the field of PAP products across broad industries and geographies” said Robin Cridland, Acting CEO of Revolymer.